The World Hip Trauma Evaluation (WHiTE) platform trial: a framework for randomized comparisons of interventions for

Matthew L Costa1, Juul Achten1, Duncan Appelbe1

  • 1Oxford Trauma and Emergency Care, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.

Bone & Joint Open
|April 1, 2025
PubMed

Insights

This study introduces a platform trial framework for efficiently comparing hip fracture treatments. It aims to provide evidence to improve patient outcomes and inform clinical guidelines for hip fracture care.

Area of Science:

  • Geriatric Medicine
  • Orthopedic Surgery
  • Clinical Trials Methodology

Background:

  • Hip fracture is a significant global health challenge, with incidence projected to increase dramatically.
  • Current management strategies require efficient evaluation of diverse interventions.

Purpose of the Study:

  • To describe a platform trial framework for evaluating multiple interventions in fragility hip fracture patients.
  • To establish a standardized approach for conducting randomized comparisons within a single trial infrastructure.

Main Methods:

  • The World Hip Trauma Evaluation (WHiTE) platform trial will enroll patients aged 60+ with hip fractures.
  • Eligible patients can participate in multiple, contemporaneous or sequential randomized comparisons.
  • A master protocol details core procedures, with specific interventions detailed in appendix protocols.

Main Results:

  • The platform trial is designed to generate robust randomized evidence on intervention effectiveness.
  • Focus on clinical and cost-effectiveness of interventions for fragility hip fractures.

Conclusions:

  • The WHiTE platform trial will yield crucial evidence to guide national and international management guidelines.
  • This framework facilitates efficient research into improving outcomes for hip fracture patients.
Abstract